United Therapeutics (UTHR) EVP Paul Mahon Exercises Options, Sells 8,300 Shares

What Happened

• Paul A. Mahon, EVP & General Counsel of United Therapeutics (UTHR), exercised 8,300 stock options at $146.03 per share (total cost $1,212,049) and sold the resulting 8,300 shares the same day (10/01/2026) in multiple open‑market trades for total proceeds of $4,689,050. The net proceeds before fees and taxes were roughly $3,477,001.
• The filing records the option exercise (transaction code M) and multiple sales (transaction code S). This was a sale (routine monetization) rather than a purchase.

Key Details

• Transaction date: 2026-10-01 (filed the same day; no late filing indicated in provided data)
• Options exercised: 8,300 shares @ $146.03 (total $1,212,049)
• Shares sold: 8,300 shares in multiple trades; sale prices reported in segments from $558.30 up to $573.15; total proceeds $4,689,050 (weighted averages used for some groups)
• Net proceeds (approx.): $3.48M before taxes/fees
• Shares owned after transaction: not specified in the provided filing
• Notable footnotes: transactions were executed pursuant to a pre‑arranged 10b5‑1 plan entered August 11, 2025; several sale lots were executed in multiple trades (price ranges and weighted averages are disclosed; detailed trade‑by‑trade info is available upon request to SEC staff/issuer)

Context

• This was essentially a cashless exercise: options were exercised and the resulting shares were immediately sold under a pre‑arranged 10b5‑1 plan. Such planned sales are commonly used by insiders to diversify or realize gains and do not necessarily signal a change in view about the company.
• Transaction codes: M = option exercise/conversion, S = open‑market sale.